| Original language | English |
|---|---|
| Pages (from-to) | 861-863 |
| Number of pages | 3 |
| Journal | The Journal of Rheumatology |
| Volume | 49 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1 Aug 2022 |
| Externally published | Yes |
Bibliographical note
Funding Information:1A. van Tubergen, MD, PhD, K. Hermans, MD, PhD candidate, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands. AvT has received unrestricted research grants from Novartis, Pfizer, and UCB, and received consulting fees from Galapagos and Novartis. KH declares no conflicts of interest relevant to this article. Address correspondence to Prof. dr. Astrid van Tubergen, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, the Netherlands. Email: [email protected].